PLUR Pluri Inc.
$1.25▲ +4.18%
Healthcare
Other
Volume 25.5K
Avg Volume (10D) 104.7K
Key Metrics & Fundamentals
Market Cap
$15.75M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.85 - 4.87
% vs 50 MA
2.25%
% vs 200 MA
-49.87%
RSI-14
59.3
MACD Histogram
+0.0500
Beta (1Y vs SPY)
0.94
Free Cash Flow
-$4.47M
Gross Rev
$335,000
Gross Profit
$196,000
EBITDA
-$5.35M
COGS
$139,000
Operating Exp
$5.74M
Operating Income
-$5.55M
EBIT
-$5.55M
Pretax Income
-$6.19M
Net Income
-$5.88M
Price & Volume History
Loading chart…
Recent News

Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments
GlobeNewswire · Oct 27, 2026 9:00 AM ET

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine
GlobeNewswire · Oct 26, 2026 7:00 AM ET

Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company
GlobeNewswire · Oct 21, 2026 8:30 AM ET

Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
GlobeNewswire · Oct 13, 2026 7:00 AM ET
Pluri: Fiscal Q4 Earnings Snapshot
Associated Press · Sep 11, 2026 2:14 AM ET

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
GlobeNewswire · Aug 27, 2026 8:00 AM ET

Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
GlobeNewswire · Aug 17, 2026 9:00 AM ET

Ever After Foods Acquires Fishway to Expand Integrated Food Production Technology Platform
GlobeNewswire · Aug 17, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PLUR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.